Total liabilities · 2013–2025
Karyopharm Therapeutics total liabilities
$401M+14.5% · FY2025
Karyopharm Therapeutics (KPTI) reported $401M in total liabilities for fiscal 2025, +14.5% year on year.
| Fiscal year | Total liabilities | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $401M | +14.5% | Open → |
| FY20242024-12-31 | $350M | −7.0% | Open → |
| FY20232023-12-31 | $377M | +0.5% | Open → |
| FY20222022-12-31 | $375M | −2.6% | Open → |
| FY20212021-12-31 | $385M | +46.7% | Open → |
| FY20202020-12-31 | $263M | +7.1% | Open → |
| FY20192019-12-31 | $245M | +55.2% | Open → |
| FY20182018-12-31 | $158M | +210.9% | Open → |
| FY20172017-12-31 | $50.8M | +180.2% | Open → |
| FY20162016-12-31 | $18.1M | +6.2% | Open → |
| FY20152015-12-31 | $17.1M | +26.1% | Open → |
| FY20142014-12-31 | $13.5M | +311.4% | Open → |
| FY20132013-12-31 | $3.3M | — | Open → |
Total liabilities — Total liabilities is everything the company owes at the balance-sheet date — debt, payables, deferred revenue and provisions together. Where a filer does not tag it, we calculate it as total assets minus total equity and label the figure as calculated.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2013–2025 compound annual growth +49.2%
Total liabilities at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Karyopharm Therapeutics total liabilities |url=https://companiesranked.com/en/company/karyopharm-therapeutics/total-liabilities |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Karyopharm Therapeutics total liabilities. CompaniesRanked. https://companiesranked.com/en/company/karyopharm-therapeutics/total-liabilitiesBibTeX
@misc{companiesranked-en-company-karyopharm-therapeutics-total-liabilities-2026,
author = {{CompaniesRanked}},
title = {{Karyopharm Therapeutics total liabilities}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/karyopharm-therapeutics/total-liabilities}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001193125-26-347906 · August 13, 2026
{{cite web |title=Karyopharm Therapeutics total liabilities — 10-Q (0001193125-26-347906) |url=https://www.sec.gov/Archives/edgar/data/1503802/000119312526347906/kpti-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-13}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.